CK LIFE SCIENCES INT'L., (HOLDINGS) INC.

CK Life Sciences Int'l., (Holdings) Inc.

775 KYG2176J1058

Food Processing

Market Closed - Hong Kong S.E. Other stock markets 04:08:15 2024-04-18 am EDT			5-day change	1st Jan Change
0.34 ^HKD	0.00%		-12.82%	-45.16%

Apr. 05	CK Life Sciences to Present Pre-Clinical Data for Two Cancer Vaccines; Shares Up 11%	MT
Mar. 19	CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Ck Life Sciences Int'l., Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2018

March 19, 2019 at 06:57 am EDT

CK Life Sciences Int'l., Holdings Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was HKD 5,232.992 million compared to HKD 4,693.133 million a year ago. Net income was HKD 263.001 million compared to HKD 258.402 million a year ago. Basic earnings per share was HKD 0.0274 compared to HKD 0.0269 a year ago.

Latest news about CK Life Sciences Int'l., (Holdings) Inc.

CK Life Sciences to Present Pre-Clinical Data for Two Cancer Vaccines; Shares Up 11%	Apr. 05	MT
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19	CI
XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models Using AI and Biomarker Data	Nov. 05	CI
CK Life Sciences to Present Preclinical Study of Cancer Vaccines at US Immunotherapy Conference	Nov. 01	MT
Ck Life Sciences Int'l., Inc. Announces Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-Targeting Prame and PD-L1	Nov. 01	CI
CK Life Sciences International's Profit Slumps 43% in H1; Shares Down 3%	23-08-16	MT
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-01	CI
CK Life Sciences Int'l., Inc. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payment Date 05 June 2023	23-03-14	CI
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
XtalPi Inc. and CK Life Sciences to Collaborate in Ai-Empowered Tumour Vaccine Research and Development, Opening A New Paradigm for Scientific Innovation	22-11-24	CI
CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee	22-09-01	CI
CK Life Sciences' H1 Profit Down 35%	22-08-02	MT
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-02	CI
CK Life Sciences Investors Acquire Stake in Pharus for $5.5 Million Each	22-07-26	MT
CK Life Sciences Int'l., Inc. Announces Ordinary Final Cash Dividend for the Year Ended 31 December 2021, Payable on 01 June 2022	22-03-15	CI
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-15	CI
CK Life Sciences Int'l., Inc. acquired Gale Road vineyard.	22-03-14	CI
CK Hutchison : CK Asset profits rise in H1	21-08-05	RE
CK Life Sciences 'l : Posts Higher Profit, Revenue in H1	21-08-04	MT
Ck Life Sciences Int'l., Holdings Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-03	CI
CK Life Sciences 'l : ' Profit Slumps 31% in 2020 as Pandemic Hits	21-03-17	MT
Ck Life Sciences Int'l., Inc. Recommends Final Dividend for the Year Ended 31 December 2020, Payable on May 31, 2021	21-03-16	CI
Ck Life Sciences Int'l., Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-16	CI
Market Chatter: Twenty-Nine Hong Kong-Listed Firms Added to Shenzhen-Hong Kong Trading Link	21-03-15	MT
Chong Kin : Hong Kong's CK Group buys first Canadian renewable power project	21-02-04	RE

Chart CK Life Sciences Int'l., (Holdings) Inc.

Duration

Period

Chart CK Life Sciences Int'l., (Holdings) Inc.

More charts

Company Profile

CK Life Sciences Intl (Holdings) Inc is an investment holding company principally engaged in the development and sales of healthcare products. The Company operates through two segments. The Health segment is engaged in the development, production, marketing and sales of healthcare and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others.

Sector

Food Processing

Calendar

2024-07-29 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
CK LIFE SCIENCES INT'L., (HOLDINGS) INC.	-45.16%	417M
ZHEJIANG NHU COMPANY LTD.	+2.48%	7.39B
BELLRING BRANDS, INC.	-2.16%	7.11B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-0.68%	5.98B
THE SIMPLY GOOD FOODS COMPANY	-18.16%	3.27B
XIAMEN KINGDOMWAY GROUP COMPANY	-18.31%	1.13B
SIRIO PHARMA CO., LTD.	+2.80%	878M
USANA HEALTH SCIENCES, INC.	-18.90%	828M
HERBALIFE LTD.	-43.71%	821M
JAMIESON WELLNESS INC.	-17.43%	777M